Antitrust Investigation

With its new thalassemia drug AQVESME launching, Agios aims for blockbuster status while navigating a key safety warning and advancing a broad pipeline.

After a lengthy battle, a New York financier is cleared of all charges. Now, his lawsuit against FINRA and Capital Group challenges the system itself.

A federal court blocked Edwards Lifesciences' key acquisition, citing monopoly fears, yet the company's financial outlook surprisingly improves.

Online education giant Stride, Inc. is embroiled in a legal battle over claims of inflated enrollment, systemic failures, and a 54% stock crash.

Distressed debt giant Silver Point Capital acquires a controlling interest in claims against bankrupt auto parts maker First Brands, a strategic move.

With industry veteran Don Cantow at the helm, Altium aims to unify electronics design on an open platform, accelerating its post-Renesas acquisition strategy.

New Era Energy & Digital faces a major fraud lawsuit from New Mexico over abandoned oil wells, threatening its pivot to a high-tech data center future.

As 'GLP-1 patch' ads flood social media for New Year's, an investigation reveals misleading marketing, a lack of science, and complex global companies.

Customers face a 3% interim water rate hike in January as regulators review a plan that could see bills climb over 30% to fund infrastructure.

Yodo1’s Transformers: Earth Wars just shifted 57% of its revenue to a webshop, proving a new DTC model is challenging Apple and Google’s dominance.

INOVIO's promising non-surgical treatment for a rare disease faces FDA scrutiny, casting doubt on its fast-track approval and impacting patient hopes.

After a 600%+ stock surge and an abrupt SEC trading halt, Charming Medical is now facing class action lawsuits alleging a social media manipulation scheme.

A popular countertop choice is fueling a deadly, incurable lung disease among workers, sparking a public health crisis and a race for safer alternatives.

A key 2026 legal forum reveals the DOJ's expanding False Claims Act focus, putting cybersecurity non-compliance and private equity investors on notice.

When a trusted professional evades over $1 million in taxes, the impact goes beyond the courtroom, shaking public trust and starving community services.

A massive breach at fintech pioneer Prosper exposes 17.6M users' SSNs and bank data, sparking a crisis of trust and security questions for the industry.

As consumer debt soars, a key advocacy group's new data-focused leadership could turn a powerful analytical lens on the role of healthcare and drug prices.

Hedge fund Balyasny Asset Management reveals a major stake in the Unite-Empiric takeover, signaling a high-stakes arbitrage play amid regulatory scrutiny.

The medtech giant projects robust growth with an ambitious pipeline, but a high-stakes regulatory showdown over a key acquisition could redefine its future.